US Map / Maryland

State MD

Clinical Trials in Maryland

Recruiting clinical trials with at least one study location in Maryland. Data updated daily from ClinicalTrials.gov.

Total Trials

384

Recruiting Now

384

← Back to US Map

Top Conditions in Maryland

Breast Cancer (9)Prostate Cancer (8)Chronic Lymphocytic Leukemia (5)Small Lymphocytic Lymphoma (5)Opioid Use Disorder (4)Head and Neck Squamous Cell Carcinoma (4)COVID-19 (4)Bladder Cancer (4)Lung Cancer (4)Asthma (4)Multiple Myeloma (4)Atopic Dermatitis (4)

Frequently Asked Questions — Clinical Trials in Maryland

How many clinical trials are currently recruiting in Maryland?

ClinicalMetric currently tracks 384 actively recruiting clinical trials with at least one location in Maryland. The total number of registered studies—including active but not currently enrolling trials—is 384. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.

What types of clinical trials are available in Maryland?

Maryland hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Prostate Cancer, Chronic Lymphocytic Leukemia, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Maryland serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.

How do I join a clinical trial near me in Maryland?

To join a clinical trial in Maryland, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Maryland maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Maryland

NCT07099053 N/A

Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging

National Institute on Aging (N

NCT05109429 N/A

Developing a Clinical Outcome Assessment for Opioid Craving

Johns Hopkins University

NCT05375812 N/A

NIH Investigative Deep Phenotyping Study of Gulf War Veteran Health (Project NIH...

Gulf War Illness

National Institute of Neurolog

NCT06034002 Phase 1

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination W...

Myeloproliferative Neoplasms

Incyte Corporation

NCT00001778 N/A

Evaluation of Patients With HAM/TSP

HTLV-I Infection

National Institute of Neurolog

NCT07288138 Phase 2

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicar...

Metabolic Dysfunction-associated Steatohepatitis

NCT00198068 N/A

Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiph...

Systemic Lupus Erythematosus

United States, Canada, United Kingdom

Hospital for Special Surgery,

NCT05317858 Phase 3

Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standar...

United States, Canada, South Korea

NCT07067138 N/A

A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advan...

National Cancer Institute (NCI

NCT05869955 Phase 1

A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Seve...

Systemic Lupus Erythematosus

United States, Belgium, France

Juno Therapeutics, Inc., a Bri

NCT05320835 N/A

A Setting Focus Overdose Prevention Intervention

Johns Hopkins Bloomberg School

NCT07247058 Phase 4

Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS)

Mild Autonomous Cortisol Secretion (MACS)

Johns Hopkins University

NCT03949855 Phase 2

Belimumab With Rituximab for Primary Membranous Nephropathy

Membranous Nephropathy

National Institute of Allergy

NCT05145491 N/A

Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM

Epiretinal Membrane

United States, United Kingdom

Jaeb Center for Health Researc

NCT06012240 Phase 3

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adul...

Alopecia Areata

United States, Argentina, Australia

NCT05459402 Phase 2, Phase 3

Divided or Single Exposure (DOSE) Study

Opioid Use Disorder

University of Maryland, Baltim

NCT06103201 Phase 1

Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury

Traumatic Brain Injury

University of Maryland, Baltim

NCT06149481 Phase 1, Phase 2

Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vacc...

Metastatic Colorectal Cancer

National Cancer Institute (NCI

NCT00060541 N/A

Evaluation and Treatment of Neurosurgical Disorders

Neurologic Disorders

National Institute of Neurolog

NCT04269902 Phase 3

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia...

Chronic Lymphocytic Leukemia

United States, Canada

National Cancer Institute (NCI

NCT05444465 N/A

Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thicknes...

Rotator Cuff Injuries

United States, Australia, Canada

Smith & Nephew, Inc.

NCT07166094 Phase 3

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Inves...

Endometrial Cancer

United States, Australia, Belgium

NCT06649812 Phase 2

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients...

High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements

National Cancer Institute (NCI

NCT05452772 Phase 2

5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder

Tobacco Use Disorder

Johns Hopkins University

NCT06624839 Phase 2

Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People ...

Human Papilloma Virus

University of Maryland, Baltim

Page 4 of 16 — 384 trials total

← Prev Next →

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology